Recent News

• 02.26.2025 - Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements
• 02.26.2025 - Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements
• 02.24.2025 - Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives
• 02.24.2025 - Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives
• 02.05.2025 - Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device
• 02.05.2025 - Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device
• 01.28.2025 - Eyenovia Announces 1-for-80 Reverse Stock Split
• 01.28.2025 - Eyenovia Announces 1-for-80 Reverse Stock Split
• 01.15.2025 - Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders
• 01.15.2025 - Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders

Recent Filings

• 02.25.2025 - 8-K Current report
• 02.24.2025 - 8-K Current report
• 01.31.2025 - 8-K Current report
• 01.28.2025 - EX-99.1 EX-99.1
• 01.28.2025 - 8-K Current report
• 01.24.2025 - 8-K Current report
• 01.16.2025 - 8-K Current report
• 01.16.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 01.15.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material